Prof. Marco Falasca.

“We could make that little bit of hope a bit bigger,” says Curtin Health Innovation Research Institute (CHIRI) researcher Professor Marco Falasca, on news his potential new treatment for pancreatic cancer is moving into clinical trials.

Curtin University is conducting the clinical trials, which will see pancreatic cancer patients in Western Australia offered a medicinal cannabis compound.

This step follows encouraging results in laboratory tests, which have Marco hopeful he has found a way of halting the progression of what is one of the most deadly forms of cancer.

Read more about Marco’s research and the trials in the article Cannabis compound gives hope to patients with pancreatic cancer.